In January 2025, we reported that some adverse events associated with gabapentin (Neurontin) may have been overestimated. Since then, new risks related to gabapentin emerged and prescribing continued ...
New use of gabapentin (Neurontin) was not associated with greater risk of falls in older adults with neuropathy or fibromyalgia compared with new use of duloxetine (Cymbalta), a commercial claims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results